In cancers, the crucial expression of FSP1 can predict the effectiveness of iron apoptosis-inducing medications, which function alongside the traditional glutathione-dependent GPX4 pathway as a strong inhibitor of ferroptosis [27]. This evidence concerns the gene GPX4 and cancer.